Navigation Links
Ruthigen Reports Fiscal First Quarter 2015 Financial Results
Date:8/14/2014

certainties. These statements are often, but not always, made through the use of words or phrases such as "anticipates," "expects," "plans," "believes," "intends," and similar words or phrases.  These forward-looking statements include, without limitation, statements regarding the timing, progress and anticipated results of the clinical development of RUT58-60, including the timing of the initiation of planned clinical trials of RUT58-60 and regulatory submissions, statements regarding the indications for which we may seek approval of RUT58-60, statements regarding our ability to fund further development of our clinical programs, our ability to achieve our milestones, as well as Ruthigen's strategy, future operations, outlook, future financial position, future financial results, plans and objectives.  We may not actually achieve these plans, intentions or expectations and we caution investors not to place undue reliance on our forward-looking statements.  Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make.  Various important factors could cause actual results or events to differ from the forward-looking statements that we make.  Such factors include, among others, risks and uncertainties associated with the results of clinical trials, which may not support our claims or beliefs concerning the safety and effectiveness of RUT58-60, our ability to obtain and maintain regulatory approval of RUT58-60 and any other product candidates we may develop, the labeling under any approval we may obtain, our ability to finance the development of RUT58-60, approvals for clinical trials, which may be delayed or withheld by regulatory agencies, regulatory risks, risk that our pre-clinical studies and clinical trials may not be successful or confirm earlier results or meet expectations or meet regulatory requirements or meet performance thresholds for commercial succe
'/>"/>
SOURCE Ruthigen, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ruthigen Treats First Human Subjects In Clinical Trial For RUT58-60
2. Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins. Conference call scheduled for 10 a.m. ET today.
3. Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins
4. CASI Pharmaceuticals Reports Second Quarter 2014 Financial Results
5. VirtualScopics, Inc. Reports Second Quarter and Six Months 2014 Financial Results; Awards Outstanding and Bookings Reflect a Two-Fold Increase Over 2013 First Six Months
6. PDI Reports 2014 Second Quarter Financial Results
7. Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results
8. Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results
9. Egalet Reports Second Quarter 2014 Financial Results and Provides Business Update
10. Aratana Therapeutics Reports Second Quarter 2014 Results
11. Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... MILL VALLEY, Calif. , Sept. 17, 2014 ... a partnership in the fight against sarcoma. Under ... Alliance Suzanne Renee Leider Memorial Assistance Fund. ... to reimburse sarcoma patients for expenses directly related ... specialist. Scientific literature reinforces the importance of this ...
(Date:9/17/2014)... Sept. 17, 2014  Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that agreement has been reached with the ... design of a pivotal, Phase 3 clinical trial ... treatment of cutaneous T-cell lymphoma (CTCL).  ...
(Date:9/16/2014)... Massachusetts , 17. September 2014 ... HOLX ), hat heute die ... zur präanalytischen Probenverarbeitung, in Europa bekannt ... gekennzeichnete, vollautomatisierte Universalplattform zur Vereinfachung der ... dass ineffiziente und fehlerbehaftete Arbeitsschritte bei ...
Breaking Medicine Technology:Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 2Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 3Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 4Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 5Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 6Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 7Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3
... Inspiration Biopharmaceuticals, Inc. (Inspiration), the only ... of new treatment options for people with hemophilia, is ... as Chief Executive Officer. Mr. Butler replaces Michael Griffith, ... Officer and is retaining the title of President at ...
... 11, 2011 Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ... financial results on Tuesday, October 25, 2011 after the close ... conference call and slide presentation via webcast on Tuesday, October ... to discuss results and highlights of the third quarter, as ...
Cached Medicine Technology:Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer 2Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer 3Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011 2
(Date:9/17/2014)... 17, 2014 With the development ... functions of adjusting human body physiology, preventing diseases, ... popularity with a variety of specific populations. In ... China reached RMB187.4 billion, up 12.0% year on ... , China's health product industry is composed of ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 U.S. ... hospitals in the country, and three mesothelioma treatment ... treatment facilities, the mesothelioma law firm Baron ... Cancer Center, University of Texas MD Anderson Cancer ... by the publication. ( http://health.usnews.com/best-hospitals/rankings/cancer ) , U.S. ...
(Date:9/17/2014)... FL (PRWEB) September 17, 2014 ... with Ed Begley, Jr., scheduled to broadcast on ... via Discovery Channel. , In this episode, Innovations ... House of Freedom’s mission to provide each client ... and spiritual well being; using the principles of ...
(Date:9/17/2014)... 2014 Experienced dress company, Discount-Dress.com, announces ... selection of trendy black bridesmaid dresses. Furthermore, the company ... beautiful bridesmaid outfits. Readers can view more ... Discount-Dress.com is a famous brand of special occasion ... as well as revamped old editions, the supplier has ...
(Date:9/17/2014)... Headquartered in Baltimore, Maryland, Therapy Pets Unlimited ... , “The past two weeks have been amazing,” ... over 400 evaluators in 46 states, and we’re still ... and South Dakota and Vermont. And from there, we ... can visit.” , TPU provides one-of-a-kind treatment to facilities ...
Breaking Medicine News(10 mins):Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:Therapy Pets Unlimited is Expanding 2Health News:Therapy Pets Unlimited is Expanding 3
... of a molecular community in brain cells of mammals ... of new drugs. Researchers from Mount Sinai School // ... latest issue of journal Science. , ,The study ... within these communities enable groups of molecules and proteins ...
... the spice turmeric its yellow color, has come under ... its cancer-fighting abilities // . ,Researchers say ... block a key protein associated with esophageal cancer, known ... “ a shot in the arm for research,” ...
... time for meditation, yoga or even a trip to ... very compact these days. Thanks to the Chocolate-coated stress ... soon. ,The chocolate-like product comprises various nutraceutical herbs ... been developed by National Botanical Research Institute (NBRI), Lucknow., ...
... A protein that protects the body from tissue damage has ... protein helps the body's healthy cells survive the effects of ... found to encourage the growth of tumors in mice following ... urethane, a lung-specific carcinogen, on two sets of mice, which ...
... Mark A. Fishel, M.D., from the University of Washington, ... increase in Alzheimer’s disease. Moderately elevated levels of ... // in plasma and in cerebrospinal fluid and these ... was conducted in 16 healthy older adults ranging in ...
... from UCLA had found out that a deficient gene ... enzyme in the vision cycle that causes congenital blindness ... disease // called Leber congenital amaurosis is published in ... suggest that replacement of RPE65, which is lacking in ...
Cached Medicine News:Health News:The effects of Curcumin: a natural pigment in turmeric explored for its anti-cancer properties 2Health News:Enzyme Responsible For Congenital Blindness 2
... Accu-Temp Cauteries provide a ... for cauterization in a wide ... single use cautery is packaged ... cap to lock switch in ...
... provide a broad selection of tip ... variety of ophthalmic procedures. Each single ... with a safety cap to lock ... when not in use, and carries ...
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... Luminary LASIK Light Probes provide the surgeon ... the corneal interface to be easily visualized ... the Tindal effect and light scatter technique, ... debris, epithelial deposits, flap edge folds, corneal ...
Medicine Products: